CAPTRUST Financial Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.1M | Buy |
44,169
+1,534
| +4% | +$569K | 0.03% | 440 |
|
|
2026
Q1 | $12.5M | Sell |
42,635
-582
| -1% | -$191K | 0.02% | 482 |
|
|
2025
Q4 | $15.1M | Buy |
43,217
+564
| +1% | +$191K | 0.03% | 399 |
|
|
2025
Q3 | $13.8M | Buy |
42,653
+117
| +0.3% | +$36.4K | 0.03% | 404 |
|
|
2025
Q2 | $16.5M | Sell |
42,536
-1,156
| -3% | -$465K | 0.04% | 352 |
|
|
2025
Q1 | $19M | Buy |
43,692
+2,512
| +6% | +$1.01M | 0.05% | 297 |
|
|
2024
Q4 | $15.2M | Buy |
41,180
+2,206
| +6% | +$923K | 0.04% | 290 |
|
|
2024
Q3 | $20.3M | Buy |
38,974
+286
| +0.7% | +$153K | 0.06% | 232 |
|
|
2024
Q2 | $21M | Buy |
38,688
+552
| +1% | +$292K | 0.07% | 217 |
|
|
2024
Q1 | $19.8M | Sell |
38,136
-18,623
| -33% | -$9.26M | 0.07% | 222 |
|
|
2023
Q4 | $26.8M | Sell |
56,759
-933
| -2% | -$431K | 0.09% | 187 |
|
|
2023
Q3 | $25.1M | Buy |
57,692
+2,729
| +5% | +$1.24M | 0.1% | 175 |
|
|
2023
Q2 | $24.4M | Buy |
54,963
+1,506
| +3% | +$695K | 0.1% | 175 |
|
|
2023
Q1 | $24.6M | Buy |
53,457
+4,519
| +9% | +$2.15M | 0.11% | 166 |
|
|
2022
Q4 | $25.1M | Buy |
48,938
+599
| +1% | +$304K | 0.13% | 156 |
|
|
2022
Q3 | $22M | Sell |
48,339
-359
| -0.7% | -$172K | 0.13% | 151 |
|
|
2022
Q2 | $23.5M | Buy |
48,698
+4,428
| +10% | +$2.19M | 0.15% | 137 |
|
|
2022
Q1 | $21.7M | Buy |
44,270
+9,776
| +28% | +$4.47M | 0.14% | 154 |
|
|
2021
Q4 | $16M | Sell |
34,494
-691
| -2% | -$291K | 0.11% | 178 |
|
|
2021
Q3 | $13.1M | Buy |
35,185
+1,330
| +4% | +$505K | 0.11% | 180 |
|
|
2021
Q2 | $12.9M | Buy |
33,855
+264
| +0.8% | +$101K | 0.12% | 171 |
|
|
2021
Q1 | $12.1M | Buy |
33,591
+4,060
| +14% | +$1.31M | 0.13% | 164 |
|
|
2020
Q4 | $9.48M | Sell |
29,531
-184
| -0.6% | -$56.5K | 0.13% | 163 |
|
|
2020
Q3 | $8.03M | Sell |
29,715
-274
| -0.9% | -$73.7K | 0.13% | 163 |
|
|
2020
Q2 | $8.06M | Buy |
29,989
+300
| +1% | +$80K | 0.13% | 160 |
|
|
2020
Q1 | $6.36M | Sell |
29,689
-7,830
| -21% | -$2.13M | 0.14% | 160 |
|
|
2019
Q4 | $11.3M | Buy |
37,519
+9,710
| +35% | +$2.67M | 0.18% | 142 |
|
|
2019
Q3 | $6.68M | Sell |
27,809
-293
| -1% | -$80.3K | 0.23% | 95 |
|
|
2019
Q2 | $7.93M | Buy |
28,102
+1,162
| +4% | +$317K | 0.29% | 71 |
|
|
2019
Q1 | $7.73M | Buy |
26,940
+5,120
| +23% | +$1.48M | 0.31% | 64 |
|
|
2018
Q4 | $5.73M | Sell |
21,820
-408
| -2% | -$112K | 0.31% | 72 |
|
|
2018
Q3 | $6.09M | Buy |
22,228
+13,600
| +158% | +$3.53M | 0.27% | 71 |
|
|
2018
Q2 | $2.05M | Buy |
8,628
+2,535
| +42% | +$587K | 0.11% | 112 |
|
|
2018
Q1 | $1.34M | Sell |
6,093
-1,357
| -18% | -$319K | 0.08% | 139 |
|
|
2017
Q4 | $1.68M | Buy |
7,450
+3,171
| +74% | +$675K | 0.1% | 121 |
|
|
2017
Q3 | $999K | Buy |
+4,279
| New | +$814K | 0.08% | 108 |
|
Other funds holding ELV
CAPTRUST Financial Advisors's ELV Position: Q2 2026 in Review
CAPTRUST Financial Advisors increased its Elevance Health (ELV) stake by 3.6% in Q2 2026, buying an estimated $569K and bringing the position to 44,169 shares worth $17.1M. The position accounts for 0.03% of the portfolio, ranked #440.
CAPTRUST Financial Advisors first reported a position in ELV in Q3 2017 and has held it in 36 quarters since. The position peaked at $26.8M in Q4 2023. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- CAPTRUST Financial Advisors held 44,169 shares of Elevance Health worth $17.1M as of Q2 2026.
- CAPTRUST Financial Advisors bought 1,534 Elevance Health shares in Q2 2026, an estimated $569K.
- Elevance Health made up 0.03% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #440 holding.
- CAPTRUST Financial Advisors first reported a position in Elevance Health in Q3 2017 and has held it in 36 quarters since.
- CAPTRUST Financial Advisors's Elevance Health position peaked at $26.8M in Q4 2023.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.